How State Scrutiny Is Impacting Healthcare Private Equity Ownership

How State Scrutiny Is Impacting Healthcare Private Equity Ownership

Created by Grace Totman, Co-Head of Capstone’s Healthcare Practice

Regulatory scrutiny around healthcare consolidation – specifically private equity investments – has increased over the past couple of years. Although federal investigations often receive the most headline attention, Capstone believes that state-level scrutiny will be more impactful in the long term and should be top of mind for investors. This scrutiny often manifests in “notice” or disclosure requirements, which we estimate exist in at least ten states. These laws require disclosure of transactions (at certain thresholds) involving a healthcare entity. Notice laws also typically target acquisitions of or investments in provider groups, reflecting a focus on Physician Practice Management (PPM) rollups.  

In this tracker, Capstone provides analysis of the existing state-level regulation/legislation in this space, including applicability, materiality thresholds, and particular reporting requirements.

Grace Totman

Grace Totman, Co-Head of Capstone’s Healthcare Practice

Read more Capstone coverage on Healthcare Private Equity Ownership:
The New Front in the Private Equity Healthcare Battle: State AGs
Healthcare Pressure Points, Opportunities, and Questions for the Balance of 2024
Private Equity’s Healthcare Problem

Have a question?

We want to hear from you. Let us know your question and a research analyst will get back to you promptly. We love to discuss our research.

Connect

Our Latest Insights

The EU Moves Toward A Russian Gas Ban

The EU Moves Toward A Russian Gas Ban

October 15, 2025 It has been three-and-a-half years since Russia invaded Ukraine, setting off efforts to punish Russia by isolating it from global markets. However, Russia’s importance as a supplier to global energy markets has complicated these efforts, and it has...